These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 33894367)

  • 1. Cell-intrinsic effects of TorsinA(ΔE) disrupt dopamine release in a mouse model of TOR1A dystonia.
    Downs AM; Fan X; Kadakia RF; Donsante Y; Jinnah HA; Hess EJ
    Neurobiol Dis; 2021 Jul; 155():105369. PubMed ID: 33894367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of M4 muscarinic receptors on striatal cholinergic interneurons normalizes striatal dopamine release in a mouse model of TOR1A dystonia.
    Downs AM; Donsante Y; Jinnah HA; Hess EJ
    Neurobiol Dis; 2022 Jun; 168():105699. PubMed ID: 35314320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice.
    Yokoi F; Oleas J; Xing H; Liu Y; Dexter KM; Misztal C; Gerard M; Efimenko I; Lynch P; Villanueva M; Alsina R; Krishnaswamy S; Vaillancourt DE; Li Y
    Neurobiol Dis; 2020 Feb; 134():104638. PubMed ID: 31618684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia.
    Martella G; Maltese M; Nisticò R; Schirinzi T; Madeo G; Sciamanna G; Ponterio G; Tassone A; Mandolesi G; Vanni V; Pignatelli M; Bonsi P; Pisani A
    Neurobiol Dis; 2014 May; 65():124-32. PubMed ID: 24503369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Transgenic Mouse Model to Investigate the Cell-Autonomous Effects of torsinA(ΔE) Expression in Striatal Output Neurons.
    Gonzalez-Alegre P; Beauvais G; Martin J; Koch RJ; Walker RH; Patel JC; Rice ME; Ehrlich ME
    Neuroscience; 2019 Dec; 422():1-11. PubMed ID: 31669362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic dysregulation produced by selective inactivation of the dystonia-associated protein torsinA.
    Sciamanna G; Hollis R; Ball C; Martella G; Tassone A; Marshall A; Parsons D; Li X; Yokoi F; Zhang L; Li Y; Pisani A; Standaert DG
    Neurobiol Dis; 2012 Sep; 47(3):416-27. PubMed ID: 22579992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tor1a+/- mice develop dystonia-like movements via a striatal dopaminergic dysregulation triggered by peripheral nerve injury.
    Ip CW; Isaias IU; Kusche-Tekin BB; Klein D; Groh J; O'Leary A; Knorr S; Higuchi T; Koprich JB; Brotchie JM; Toyka KV; Reif A; Volkmann J
    Acta Neuropathol Commun; 2016 Oct; 4(1):108. PubMed ID: 27716431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse Mechanisms Lead to Common Dysfunction of Striatal Cholinergic Interneurons in Distinct Genetic Mouse Models of Dystonia.
    Eskow Jaunarajs KL; Scarduzio M; Ehrlich ME; McMahon LL; Standaert DG
    J Neurosci; 2019 Sep; 39(36):7195-7205. PubMed ID: 31320448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced mu opioid receptor-dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia.
    Ponterio G; Tassone A; Sciamanna G; Vanni V; Meringolo M; Santoro M; Mercuri NB; Bonsi P; Pisani A
    Mov Disord; 2018 Feb; 33(2):310-320. PubMed ID: 29150865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function of dopamine transporter is compromised in DYT1 transgenic animal model in vivo.
    Hewett J; Johanson P; Sharma N; Standaert D; Balcioglu A
    J Neurochem; 2010 Apr; 113(1):228-35. PubMed ID: 20132487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral nerve injury elicits microstructural and neurochemical changes in the striatum and substantia nigra of a DYT-TOR1A mouse model with dystonia-like movements.
    Rauschenberger L; Krenig EM; Stengl A; Knorr S; Harder TH; Steeg F; Friedrich MU; Grundmann-Hauser K; Volkmann J; Ip CW
    Neurobiol Dis; 2023 Apr; 179():106056. PubMed ID: 36863527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic background modulates the phenotype of a mouse model of DYT1 dystonia.
    Tanabe LM; Martin C; Dauer WT
    PLoS One; 2012; 7(2):e32245. PubMed ID: 22393392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia.
    Scarduzio M; Zimmerman CN; Jaunarajs KL; Wang Q; Standaert DG; McMahon LL
    Exp Neurol; 2017 Sep; 295():162-175. PubMed ID: 28587876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia.
    Sciamanna G; Ponterio G; Tassone A; Maltese M; Madeo G; Martella G; Poli S; Schirinzi T; Bonsi P; Pisani A
    Neuropharmacology; 2014 Oct; 85():440-50. PubMed ID: 24951854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia.
    Song CH; Fan X; Exeter CJ; Hess EJ; Jinnah HA
    Neurobiol Dis; 2012 Oct; 48(1):66-78. PubMed ID: 22659308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the direct pathway in Dyt1 ΔGAG heterozygous knock-in mice and dopamine receptor 1-expressing-cell-specific Dyt1 conditional knockout mice.
    Yokoi F; Chen HX; Oleas J; Dang MT; Xing H; Dexter KM; Li Y
    Behav Brain Res; 2021 Aug; 411():113381. PubMed ID: 34038798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine release is impaired in a mouse model of DYT1 dystonia.
    Balcioglu A; Kim MO; Sharma N; Cha JH; Breakefield XO; Standaert DG
    J Neurochem; 2007 Aug; 102(3):783-8. PubMed ID: 17550429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trihexyphenidyl rescues the deficit in dopamine neurotransmission in a mouse model of DYT1 dystonia.
    Downs AM; Fan X; Donsante C; Jinnah HA; Hess EJ
    Neurobiol Dis; 2019 May; 125():115-122. PubMed ID: 30707939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forebrain deletion of the dystonia protein torsinA causes dystonic-like movements and loss of striatal cholinergic neurons.
    Pappas SS; Darr K; Holley SM; Cepeda C; Mabrouk OS; Wong JM; LeWitt TM; Paudel R; Houlden H; Kennedy RT; Levine MS; Dauer WT
    Elife; 2015 Jun; 4():e08352. PubMed ID: 26052670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of endoplasmic reticulum stress reverses synaptic plasticity deficits in striatum of DYT1 dystonia mice.
    Cai H; Ni L; Hu X; Ding X
    Aging (Albany NY); 2021 Aug; 13(16):20319-20334. PubMed ID: 34398825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.